Skip to content

Effect Of Nigella Sativa Oil for the Treatment of Hypertension

Effect Of Nigella Sativa Oil for the Treatment of Hypertension

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07055763
Enrollment
60
Registered
2025-07-09
Start date
2022-03-17
Completion date
2026-02-28
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

My research explores the antihypertensive effects of Nigella sativa (black seed) oil in managing high blood pressure. Hypertension is a growing global health concern, often insufficiently controlled by standard medications. Nigella sativa, known for its bioactive compound thymoquinone, possesses antioxidant, anti-inflammatory, and vasodilatory properties, making it a potential natural remedy for blood pressure regulation.

Interventions

COMBINATION_PRODUCTNigella sativa (black seed)

Participants in Group 1 (intervention group) will receive Nigella sativa (black seed) oil at a dosage of 0.5 ml, administered orally twice daily-once before breakfast and once before bedtime-for a duration of 12 weeks. The oil, sourced from a standardized local supplier, is rich in thymoquinone, known for its antioxidant and vasodilatory properties. Blood pressure will be measured at baseline and biweekly intervals using a calibrated digital sphygmomanometer to monitor changes in systolic and diastolic values. Participants will also be monitored regularly for any adverse effects.

Sponsors

Superior University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 30 to 70 years * Diagnosed with mild to moderate hypertension (BP ≥140/90 mmHg) * Willing to participate and provide written informed consent * Not currently on any herbal or nutritional supplements

Exclusion criteria

* History of smoking or alcohol consumption * Pregnant, postmenopausal, or breastfeeding women * Use of dietary supplements or medications containing antioxidants, caffeine, estrogen, or steroids * Individuals engaging in regular vigorous physical exercise * Those adding extra salt to their meals * Known allergy to Nigella sativa or black seed oil

Design outcomes

Primary

MeasureTime frameDescription
Structured Patient History Questionnaire12 MonthsA pre-designed, structured questionnaire will be used at baseline to collect demographic information, medical history, medication use, dietary habits, and lifestyle factors. This is a qualitative tool without a scoring system but is essential for eligibility confirmation and contextual analysis

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026